Imaging-Based Modalities Compared for Identifying At-Risk MASH

FRIDAY, Oct. 16, 2026-- FibroScan-aspartate aminotransferase (FAST) demonstrated the highest sensitivity for ruling out at-risk metabolic dysfunction-associated steatohepatitis (MASH), according to a study published in the October issue of the...